Mark Donaldson, BSP, RPH, PHARMD, FASHP, FACHE
LectureThis course qualifies for providing credit for the DEA MATE Act training requirement.
Course Description
This course qualifies for providing credit for the DEA MATE Act training requirement.
On March 28, 2023 the U.S. Drug Enforcement Administration (DEA) issued guidance outlining requirements for a one-time, eight-hour training, “on the treatment and management of patients with opioid or other substance use disorders.” The Medication Access and Training Expansion (MATE) Act that was passed as part of the Consolidated Appropriations Act (CAA) of 2023 (P.L. 117-328) requires all DEA-registered providers to complete this training. This means YOU!
The deadline to satisfy this training requirement is the date of a practitioner’s next scheduled DEA registration submission beginning June 27, 2023. Practitioners will be required to check a box on their online DEA registration form to affirm that they have completed the training, regardless of whether the practitioner is a first-time applicant or is renewing their registration.
Wouldn’t it be nice to complete this requirement from the comfort of your own home and at your own pace? Wouldn’t it be nice to avoid the costs of additional travel and time in having to attend an in-person continuing educational event? Wouldn’t you like to avoid the typical four hours of pre-course work often required by these live programs? This is the course for you.
In partnership with two PACE and CERP accredited, university-based continuing educational teams, our faculty is proud to be affiliated with the Oregon Health & Sciences University and the University of Washington to bring this foundational course to your home or office. In compliance with the DEA requirements for this new comprehensive curriculum, we will cover the safe pharmacological management of dental pain and screening, brief intervention, and referral for appropriate treatment of patients with or at risk of developing opioid and other substance use disorders.
Our second module will focus on the appropriate post-operative analgesic selection and approach in helping manage these challenging patients, emphasizing strategies that focus on patient comfort and helping set you, your team and most importantly, your patients up for success. This second module is foundational in our continuum which continues the themes of patient and medication safety and focuses on successful evidence- and guideline-based strategies for appropriate postoperative analgesic prescribing.
Combined, these interactive programs will review the current clinical challenges and regulatory issues with a particular focus on the dental realm. Case studies will augment the delivery of key points and a problem-based learning approach is encouraged so that each participant’s questions are addressed.
Course Objectives
- Discuss the pathophysiology of pain as it relates to dentistry
- Understand the perfect analgesic recipe to keep (almost) all of your patients out of pain – first time, every time
- Describe the different types of analgesics available and how to match the right drug at the right dose for the right patient and the right procedure
- Explain why narcotic-containing analgesics should not be routinely prescribed for post-operative dental pain
- Describe the mechanism of action of non-steroidal anti-inflammatory medications
- Discuss the importance of consulting one’s state Prescription Drug Therapy Monitoring Program
Instructor
Mark Donaldson received his baccalaureate degree from the University of British Columbia and his Doctorate in Clinical Pharmacy from the University of Washington. He completed a residency at Vancouver General Hospital, and has practiced as a clinical pharmacy specialist, clinical coordinator and director of pharmacy services at many healthcare organizations in both Canada and the United States. He is currently the Associate Principal of Clinical Pharmacy for Vizient’s Advisory Solutions, and lives in Whitefish, Montana.
Dr. Donaldson is a Clinical Professor in the Department of Pharmacy at the University of Montana in Missoula, and Clinical Associate Professor in the School of Dentistry at the Oregon Health & Sciences University in Portland, Oregon. He has a special interest in dental pharmacology and has lectured internationally to both dental and medical practitioners. He has spent the last 20 years focusing on dental pharmacology and dental therapeutics, and is a leader in the field.
Dr. Donaldson has published numerous peer-reviewed works and textbook chapters. He currently serves on the Editorial Board for the Journal Healthcare Executive and the Journal of the American Dental Association and is a reviewer for over ten other different journals. He is board certified in healthcare management and is the Past-President and current Regent of the American College of Healthcare Executives’ Montana Chapter. Dr. Donaldson was named as the 2014 recipient of the Bowl of Hygeia for the state of Montana and is the 2016 recipient of the Dr. Thaddeus V. Weclew Award. This award is conferred upon an individual who has made outstanding contributions to the medical, dental and pharmacy literature.
Disclosures:
- Dr. Donaldson has no relevant financial relationships to disclose.
- The staff of the University of Washington Office of Continuing Dental Education have no relevant financial relationships to disclose.
Course Logistics
DATE:
Saturday, June 24, 2023
LOCATION:
Zoom live webinar
TARGET AUDIENCE:
This course is designed for dentists who prescribe or provide pain medication and antibiotics in their offices. Other dental professionals may be interested in the course content as well.
TIMES:
Course: 8:30am – 12:30pm
TUITION:
$159/Dentist
$99/Team members (dental hygienist, dental assistant, office staff)
$143/Current Dental Alumni Member
* This course is eligible for a 10% tuition discount if you are a current member of the UW Dental Alumni Association.
CREDITS:
4 hours
The University of Washington is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at CCEPR.ADA.org.
This continuing education activity has been planned and implemented in accordance with the standards of the ADA Continuing Education Recognition Program (ADA CERP) through joint efforts between the University of Washington and Oregon Health Sciences University Offices of Continuing Dental Education.
The University of Washington is a member of the Association for Continuing Dental Education.
University of Washington designates this activity for 4 continuing education credits.